Diabetes decisions — 2025

The Board denied the veteran's claims for increased ratings and service connection, as no evidence supported a higher rating or service connection.

The Board dismissed the appeals for service connection for ischemic heart disease, syncope, diabetes mellitus, Type-II, diabetic peripheral neuropathy, bilateral hearing loss, and fracture of two upper teeth due to procedural defects in the Veteran's filings.

The Board remands the claims for service connection for lymphoproliferative disorder, CAD, and DM due to a need for a VA medical opinion.

The Board denied service connection for diabetes mellitus and remanded the claims for service connection for hypertension and stroke, as further evidence is needed to determine their etiology.

The Board denied service connection for diabetes mellitus type II, prostate cancer, and peripheral neuropathy in the right and left upper and lower extremities as there was no evidence of an in-service injury or disease related to these conditions.

The Board remands the claims for service connection for diabetes mellitus, type II and hypertension due to a failure to substantially comply with prior remand directives.

The Board granted service connection for degenerative arthritis with lumbosacral strain and denied service connection for bilateral hearing loss. Other claims were remanded.

The Board denied the claim for service connection for gout and remanded the claims for service connection for type II diabetes mellitus, amputation of left leg, right lower extremity neuropathy, bilateral upper extremity neuropathy, hypertension, a vision disorder, tremors, and gout, for additional development.

The Board remands the claims for service connection for ischemic heart disease, diabetes mellitus type II, and peripheral neuropathy of various extremities to obtain additional evidence and ensure adequate medical opinions.

The Board denied service connection for diabetes mellitus II, a heart stent, chronic kidney disease stage 3, anxiety with stress, and a lumbar spine disability as the evidence did not support a finding that these conditions were incurred in or aggravated by active service.

The Board denied higher ratings for the Veteran's lumbar spine disability and type II diabetes mellitus, but granted an effective date of October 23, 2023, for special monthly compensation based on the need of aid and attendance of another.

The Board granted service connection for diabetes mellitus type II, finding sufficient evidence that the Veteran was exposed to herbicide agents during his active service in Korea.

The Board granted service connection for Type 2 diabetes mellitus based on the Veteran's exposure to herbicide agents during his active duty in Vietnam.

The Board denied service connection for cardiovascular disease, diabetes mellitus, type II, erectile dysfunction, and facial scars. The claim for TDIU was also denied.

The Board denied the Veteran's appeals to reopen claims for service connection for diabetes mellitus, hypertension, right and left lower extremity peripheral neuropathy, and remanded the claim for service connection for prostate cancer.

The Board denied the Veteran's claim for service connection for diabetes mellitus, finding no evidence of in-service incurrence or causation by active service.

The Board granted an effective date of January 12, 2023, for the grant of service connection for peripheral neuropathy, left lower extremity. Other claims were denied or remanded.

The Veteran's service connection claim for insomnia disorder was granted, while claims for other conditions including left and right hand disorders, vision decrease, hypertension, diabetes mellitus, type II, upper extremity carpal tunnel syndromes, wrist disorders were denied.

The Board granted service connection for diabetes mellitus type II as secondary to the Veteran's service-connected obstructive sleep apnea, resolving all reasonable doubt in favor of the Veteran.

The Board remands the claims for service connection for heart disease, hypertension, diabetes mellitus II, and a skin/skin rash disorder due to the RO's failure to comply with the Board's previous directive.